Ultraschall Med 2023; 44(06): 606-613 DOI: 10.1055/a-2034-1911
Original Article
HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound
(CEUS) – a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS
HCC trial
Hepatozelluläre Karzinome (HCCs) ohne arterielles Hyperenhancement (APHE) in der Kontrastmittelsonografie
(CEUS) – Erkenntnisse aus der prospektiven multizentrischen DEGUM-CEUS-HCC-Studie
Authors
Deike Strobel
1
Department of Medicine 1 Gastroenterology Endocrinology and Pneumology, Erlangen University
Hospital, Erlangen, Germany (Ringgold ID: RIN72175)
Abbas Agaimy
2
Institute of Pathoogy, Erlangen University Hospital, Erlangen, Germany (Ringgold ID: RIN27168)
Daniel Jesper
1
Department of Medicine 1 Gastroenterology Endocrinology and Pneumology, Erlangen University
Hospital, Erlangen, Germany (Ringgold ID: RIN72175)
Sebastian Zundler
1
Department of Medicine 1 Gastroenterology Endocrinology and Pneumology, Erlangen University
Hospital, Erlangen, Germany (Ringgold ID: RIN72175)